Malaysia · Delayed Price · Currency is MYR PETRONAS Chemicals Group Berhad Earnings Call Transcripts
Fiscal Year 2025
-
Q3 2025 saw improved plant utilization and higher sales, narrowing losses despite ongoing margin pressure from oversupply and weak demand. EBITDA rose 26% quarter-on-quarter, with new specialty products and sustainability initiatives supporting long-term growth.
Fiscal Year 2024
-
Revenue grew 7% year-over-year to RM 30.7 billion, but EBITDA and PAT declined due to forex losses and higher costs. Plant utilization improved to 91%, with strong F&M performance offsetting O&D and specialty segment challenges. 2025 outlook remains cautious amid persistent market headwinds.
-
Revenue grew 8% year-on-year on higher volumes, but EBITDA and PAT declined due to forex losses and higher costs, especially at PPC. Outlook remains cautious with subdued O&D prices, stable F&M, and specialty segment challenges. Plant utilization improved, but 2025 faces heavy turnarounds.
-
Revenue and EBITDA grew year-over-year, supported by higher specialty segment contribution and favorable FX, despite operational challenges and weak market conditions. Pengerang plants are set for commercial operation in Q3 2024, with cautious outlook for H2 2024.